This week, we are excited to launch a survey study designed to be the first of its kind to collect data on the impact of cannabis and cannabinoid use in women who report menopause-related symptoms. The goal of this investigation is to clarify the impact of cannabinoid-based therapies in this population. Data from this survey will also be used to determine whether further, more in-depth studies which directly assess the efficacy of cannabinoid-based products for menopause-related symptoms are warranted.
Interested in participating?